Zynerba Pharmaceuticals Inc. (ZYNE) NASDAQ
$1.30 - (-)
Market Cap: -
As of 10/10/23 12:00 AM EDT. Market closed.
Zynerba Pharmaceuticals Inc. (ZYNE)
NASDAQ
$1.30
- (-)
Market Cap: -
As of 10/10/23 12:00 AM EDT. Market closed.
Add to Portfolio
at zynerba pharmaceuticals (nasdaq: zyne), we are dedicated to developing next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. our mission is to improve the lives of patients battling severe health conditions including refractory epilepsy, osteoarthritis, fragile x syndrome, fibromyalgia and peripheral neuropathic pain ... read more
at zynerba pharmaceuticals (nasdaq: zyne), we are dedicated to developing next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. our mission is to improve the lives of patients battling severe health conditions including refractory epilepsy, osteoarthritis, fragile x syndrome, fibromyalgia and peripheral neuropathic pain through these therapeutics. our development pipeline includes patent-protected synthetic transdermal cannabinoid products, cbd gel – zyn002 and thc pro-drug patch – zyn001, which we believe will provide new treatment options for patients as well as additional treatment options for patients not currently receiving adequate relief or otherwise experiencing intolerable side effects from current treatment regimes. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Armando Anido
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
URL
Address
80 W. Lancaster Avenue, Suite 300, Pennsylvania, Devon, 19333.
PRICE CHART FOR ZYNERBA PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.30
Days Range
$1.26 - $1.34
52 week range
- - -
Volume
862,786
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
53,939,431
Open
-
Previous Close
$1.30
Days Range
$1.26 - $1.34
52 week range
- - -
Volume
862,786
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
53,939,431
FINANCIAL STATEMENTS FOR ZYNERBA PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ZYNERBA PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Sebree Terri B | President | Sep 13, 2023 | Sale | $1.33 | 12,401 | 16,440 | 596,241 | Sep 14, 2023, 04:14 PM |
| Rosenberger Brian | VP, Commercial & Business Dev. | Sep 13, 2023 | Sale | $1.33 | 6,411 | 8,499 | 249,559 | Sep 14, 2023, 04:14 PM |
| Fickenscher James E | Chief Financial Officer | Sep 13, 2023 | Sale | $1.33 | 8,998 | 11,929 | 378,087 | Sep 14, 2023, 04:13 PM |
| Jones Kenneth T | See Remarks | Sep 13, 2023 | Sale | $1.33 | 2,505 | 3,321 | 85,520 | Sep 14, 2023, 04:13 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | Sep 13, 2023 | Sale | $1.33 | 17,830 | 23,637 | 936,722 | Sep 14, 2023, 04:13 PM |
| Stephenson Pamela | Director | Jun 14, 2023 | Sale | $0.35 | 115 | 40 | 75,778 | Jun 15, 2023, 04:30 PM |
| MOCH KENNETH I | Director | Jun 14, 2023 | Sale | $0.35 | 115 | 40 | 75,778 | Jun 15, 2023, 04:30 PM |
| KISNER DANIEL L | Director | Jun 14, 2023 | Sale | $0.35 | 115 | 40 | 75,778 | Jun 15, 2023, 04:29 PM |
| FEDERICI WILLIAM J | Director | Jun 14, 2023 | Sale | $0.35 | 115 | 40 | 75,778 | Jun 15, 2023, 04:29 PM |
| Butler John P. | Director | Jun 14, 2023 | Sale | $0.35 | 115 | 40 | 80,765 | Jun 15, 2023, 04:28 PM |
| COOPER WARREN D | Director | Jun 14, 2023 | Sale | $0.35 | 115 | 40 | 75,778 | Jun 15, 2023, 04:28 PM |
| Parker Albert P | Chief Legal Officer | Feb 15, 2023 | Sale | $0.54 | 3,173 | 1,719 | 227,018 | Feb 17, 2023, 04:21 PM |
| Rosenberger Brian | VP, Commercial & Business Dev. | Feb 08, 2023 | Option Exercise | $0.60 | 5,145 | 3,069 | 233,770 | Feb 09, 2023, 05:20 PM |
| Fickenscher James E | Chief Financial Officer | Feb 08, 2023 | Option Exercise | $0.60 | 6,544 | 3,903 | 355,885 | Feb 09, 2023, 05:11 PM |
| Sebree Terri B | President | Feb 08, 2023 | Option Exercise | $0.60 | 9,973 | 5,949 | 563,642 | Feb 09, 2023, 05:11 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | Feb 08, 2023 | Option Exercise | $0.60 | 12,547 | 7,484 | 889,805 | Feb 09, 2023, 05:10 PM |
| Parker Albert P | Chief Legal Officer | Feb 08, 2023 | Option Exercise | $0.60 | 5,463 | 3,259 | 230,191 | Feb 09, 2023, 05:09 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | Feb 01, 2023 | Option Exercise | $0.60 | 11,726 | 6,979 | 856,946 | Feb 02, 2023, 08:13 PM |
| Parker Albert P | Chief Legal Officer | Feb 01, 2023 | Option Exercise | $0.60 | 5,841 | 3,477 | 216,790 | Feb 02, 2023, 08:12 PM |
| Rosenberger Brian | VP, Commercial & Business Dev. | Feb 01, 2023 | Option Exercise | $0.60 | 4,809 | 2,862 | 223,989 | Feb 02, 2023, 08:10 PM |
| Fickenscher James E | Chief Financial Officer | Feb 01, 2023 | Option Exercise | $0.60 | 5,927 | 3,528 | 339,882 | Feb 02, 2023, 08:08 PM |
| Sebree Terri B | President | Feb 01, 2023 | Option Exercise | $0.60 | 9,321 | 5,548 | 537,571 | Feb 02, 2023, 08:06 PM |
| Sebree Terri B | President | Jan 23, 2023 | Sale | $0.60 | 24,661 | 14,742 | 343,204 | Jan 25, 2023, 05:29 PM |
| Fickenscher James E | Chief Financial Officer | Jan 23, 2023 | Sale | $0.60 | 17,769 | 10,622 | 154,736 | Jan 25, 2023, 05:28 PM |
| Rosenberger Brian | VP, Commercial & Business Dev. | Jan 23, 2023 | Sale | $0.60 | 12,663 | 7,570 | 94,848 | Jan 25, 2023, 05:26 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | Jan 23, 2023 | Sale | $0.60 | 35,453 | 21,194 | 576,235 | Jan 25, 2023, 05:25 PM |
| Sebree Terri B | President | Jul 19, 2022 | Sale | $1.10 | 8,281 | 9,109 | 367,865 | Jul 20, 2022, 04:08 PM |
| Rosenberger Brian | VP, Commercial & Business Dev. | Jul 19, 2022 | Sale | $1.10 | 4,289 | 4,718 | 107,511 | Jul 20, 2022, 04:06 PM |
| Fickenscher James E | Chief Financial Officer | Jul 19, 2022 | Sale | $1.10 | 6,013 | 6,614 | 172,505 | Jul 20, 2022, 04:05 PM |
| ANIDO ARMANDO | Chairman & CEO | Jul 19, 2022 | Sale | $1.10 | 11,899 | 13,089 | 611,688 | Jul 20, 2022, 04:05 PM |
| KISNER DANIEL L | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:53 PM |
| FEDERICI WILLIAM J | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:52 PM |
| Stephenson Pamela | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:51 PM |
| MOCH KENNETH I | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:50 PM |
| COOPER WARREN D | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:49 PM |
| Butler John P. | Director | Jun 14, 2022 | Sale | $1.01 | 53 | 54 | 33,056 | Jun 16, 2022, 09:48 PM |
| Butler John P. | Director | Aug 22, 2018 | Buy | $6.43 | 5,000 | 32,153 | 5,000 | Aug 22, 2018, 04:39 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | Aug 06, 2018 | Buy | $5.96 | 15,000 | 89,423 | 352,512 | Aug 07, 2018, 04:32 PM |
| Hanlon Suzanne M. | Sec, VP & General Counsel | Aug 06, 2018 | Buy | $5.80 | 3,800 | 22,048 | 43,693 | Aug 07, 2018, 04:30 PM |
| Sebree Terri B | President | Aug 06, 2018 | Buy | $5.79 | 3,800 | 22,013 | 182,546 | Aug 07, 2018, 04:29 PM |
| Fickenscher James E | Chief Financial Officer | Aug 06, 2018 | Buy | $5.97 | 8,518 | 50,842 | 20,718 | Aug 07, 2018, 04:28 PM |
| RAPP MICHAEL | 10% Owner | May 30, 2018 | Buy | $10.45 | 5,885 | 61,498 | 1,500,000 | May 31, 2018, 09:26 AM |
| RAPP MICHAEL | 10% Owner | May 02, 2018 | Buy | $10.46 | 15,000 | 156,945 | 1,494,115 | May 02, 2018, 05:38 PM |
| RAPP MICHAEL | 10% Owner | Mar 22, 2018 | Buy | $9.28 | 10,000 | 92,790 | 1,479,115 | Mar 23, 2018, 09:30 AM |
| RAPP MICHAEL | 10% Owner | Jan 02, 2018 | Buy | $12.99 | 15,000 | 194,847 | 1,469,115 | Jan 03, 2018, 06:05 AM |
| RAPP MICHAEL | 10% Owner | Oct 23, 2017 | Buy | $9.94 | 25,745 | 255,795 | 1,454,115 | Oct 23, 2017, 07:25 PM |
| RAPP MICHAEL | 10% Owner | Oct 20, 2017 | Buy | $9.78 | 30,000 | 293,538 | 1,428,370 | Oct 23, 2017, 07:25 PM |
| RAPP MICHAEL | 10% Owner | Oct 19, 2017 | Buy | $9.59 | 44,255 | 424,405 | 1,398,370 | Oct 23, 2017, 07:25 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | May 12, 2017 | Buy | $19.76 | 3,500 | 69,160 | 336,012 | May 16, 2017, 08:50 AM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | May 15, 2017 | Buy | $19.57 | 1,500 | 29,355 | 337,512 | May 16, 2017, 08:50 AM |
| Fickenscher James E | Chief Financial Officer | May 12, 2017 | Buy | $19.82 | 5,200 | 103,064 | 12,200 | May 16, 2017, 08:50 AM |
| RAPP MICHAEL | 10% Owner | Dec 29, 2016 | Buy | $15.85 | 10,000 | 158,500 | 1,354,115 | Dec 29, 2016, 09:54 PM |
| Fickenscher James E | Chief Financial Officer | Dec 07, 2016 | Buy | $14.03 | 4,000 | 56,120 | 7,000 | Dec 08, 2016, 02:01 PM |
| Fickenscher James E | Chief Financial Officer | Dec 06, 2016 | Buy | $14.15 | 3,000 | 42,450 | 3,000 | Dec 08, 2016, 02:01 PM |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | Aug 05, 2015 | Buy | $17.92 | 3,000 | 53,760 | 3,000 | Aug 17, 2016, 02:19 PM |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | Aug 16, 2016 | Sale | $10.53 | 3,000 | 31,590 | 0 | Aug 17, 2016, 02:19 PM |
| BARON RICHARD A | Chief Financial Officer | Sep 11, 2015 | Option Exercise | $3.98 | 15,957 | 63,509 | 15,957 | Sep 15, 2015, 01:48 PM |
| HARRISON THOMAS L | Director | Aug 10, 2015 | Buy | $14.00 | 12,500 | 175,000 | 12,500 | Aug 12, 2015, 11:48 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Sebree Terri B | President | 09/13/2023 | 16,440 |
| Rosenberger Brian | VP, Commercial & Business Dev. | 09/13/2023 | 8,499 |
| Fickenscher James E | Chief Financial Officer | 09/13/2023 | 11,929 |
| Jones Kenneth T | See Remarks | 09/13/2023 | 3,321 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 09/13/2023 | 23,637 |
| Stephenson Pamela | Director | 06/14/2023 | 40 |
| MOCH KENNETH I | Director | 06/14/2023 | 40 |
| KISNER DANIEL L | Director | 06/14/2023 | 40 |
| FEDERICI WILLIAM J | Director | 06/14/2023 | 40 |
| Butler John P. | Director | 06/14/2023 | 40 |
| COOPER WARREN D | Director | 06/14/2023 | 40 |
| Parker Albert P | Chief Legal Officer | 02/15/2023 | 1,719 |
| Rosenberger Brian | VP, Commercial & Business Dev. | 02/08/2023 | 3,069 |
| Fickenscher James E | Chief Financial Officer | 02/08/2023 | 3,903 |
| Sebree Terri B | President | 02/08/2023 | 5,949 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 02/08/2023 | 7,484 |
| Parker Albert P | Chief Legal Officer | 02/08/2023 | 3,259 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 02/01/2023 | 6,979 |
| Parker Albert P | Chief Legal Officer | 02/01/2023 | 3,477 |
| Rosenberger Brian | VP, Commercial & Business Dev. | 02/01/2023 | 2,862 |
| Fickenscher James E | Chief Financial Officer | 02/01/2023 | 3,528 |
| Sebree Terri B | President | 02/01/2023 | 5,548 |
| Sebree Terri B | President | 01/23/2023 | 14,742 |
| Fickenscher James E | Chief Financial Officer | 01/23/2023 | 10,622 |
| Rosenberger Brian | VP, Commercial & Business Dev. | 01/23/2023 | 7,570 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 01/23/2023 | 21,194 |
| Sebree Terri B | President | 07/19/2022 | 9,109 |
| Rosenberger Brian | VP, Commercial & Business Dev. | 07/19/2022 | 4,718 |
| Fickenscher James E | Chief Financial Officer | 07/19/2022 | 6,614 |
| ANIDO ARMANDO | Chairman & CEO | 07/19/2022 | 13,089 |
| KISNER DANIEL L | Director | 06/14/2022 | 40 |
| FEDERICI WILLIAM J | Director | 06/14/2022 | 40 |
| Stephenson Pamela | Director | 06/14/2022 | 40 |
| MOCH KENNETH I | Director | 06/14/2022 | 40 |
| COOPER WARREN D | Director | 06/14/2022 | 40 |
| Butler John P. | Director | 06/14/2022 | 54 |
| Butler John P. | Director | 08/22/2018 | 32,153 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 08/06/2018 | 89,423 |
| Hanlon Suzanne M. | Sec, VP & General Counsel | 08/06/2018 | 22,048 |
| Sebree Terri B | President | 08/06/2018 | 22,013 |
| Fickenscher James E | Chief Financial Officer | 08/06/2018 | 50,842 |
| RAPP MICHAEL | 10% Owner | 05/30/2018 | 61,498 |
| RAPP MICHAEL | 10% Owner | 05/02/2018 | 156,945 |
| RAPP MICHAEL | 10% Owner | 03/22/2018 | 92,790 |
| RAPP MICHAEL | 10% Owner | 01/02/2018 | 194,847 |
| RAPP MICHAEL | 10% Owner | 10/23/2017 | 255,795 |
| RAPP MICHAEL | 10% Owner | 10/20/2017 | 293,538 |
| RAPP MICHAEL | 10% Owner | 10/19/2017 | 424,405 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 05/12/2017 | 69,160 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 05/15/2017 | 29,355 |
| Fickenscher James E | Chief Financial Officer | 05/12/2017 | 103,064 |
| RAPP MICHAEL | 10% Owner | 12/29/2016 | 158,500 |
| Fickenscher James E | Chief Financial Officer | 12/07/2016 | 56,120 |
| Fickenscher James E | Chief Financial Officer | 12/06/2016 | 42,450 |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | 08/05/2015 | 53,760 |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | 08/16/2016 | 31,590 |
| BARON RICHARD A | Chief Financial Officer | 09/11/2015 | 63,509 |
| HARRISON THOMAS L | Director | 08/10/2015 | 175,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ZYNERBA PHARMACEUTICALS INC
STOCK BUYBACKS FOR ZYNERBA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
3.55%
1Q
12/31/2022
11.06%
2Q
09/30/2022
14.64%
3Q
06/30/2022
21.12%
4Q
03/31/2022
24.43%
5Q
12/31/2021
24.63%
6Q
09/30/2021
25.09%
7Q
06/30/2021
25.17%
8Q
03/31/2021
25.17%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ZYNERBA PHARMACEUTICALS INC
LOADING...